Jonathon Florance, Taylor P Stauffer, Billy I Kim, Thorsten M Seyler, Michael P Bolognesi, William A Jiranek, Sean P Ryan
{"title":"Risk Factors of Failure to Discharge Before \"Two Midnights\" in Outpatient-Designated Total Hip Arthroplasty.","authors":"Jonathon Florance, Taylor P Stauffer, Billy I Kim, Thorsten M Seyler, Michael P Bolognesi, William A Jiranek, Sean P Ryan","doi":"10.5435/JAAOS-D-23-00841","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The Centers for Medicare and Medicaid Services removed total hip arthroplasty (THA) from the inpatient-only list but continued to classify admissions as inpatient if they include two midnights, complicating care if an outpatient THA requires extended hospitalization. This study evaluates risk factors of patients undergoing outpatient-designated THA with a length of stay (LOS) ≥ 2 days.</p><p><strong>Methods: </strong>A total of 17,063 THA procedures designated as outpatient in the National Surgical Quality Improvement Program database between 2015 and 2020 were stratified by LOS < 2 days (n = 2,294, 13.4%) and LOS ≥ 2 days (n = 14,765, 86.6%). Demographics, comorbidities, and outcomes were compared by univariate analysis. Multivariable regression analysis identified predictors of LOS ≥ 2 days.</p><p><strong>Results: </strong>Outpatients with extended LOS were older (mean 65.3 vs. 63.5 years; P < 0.01); were more likely to have body mass index (BMI) > 35 (24.0 vs. 17.8%; P < 0.01); and had higher incidences of smoking (15.1% vs. 10.3%; P < 0.01), diabetes (15.4% vs. 9.9%; P < 0.01), chronic obstructive pulmonary disease (4.4% vs. 2.3%; P < 0.01), and hypertension (57.6% vs. 49.2%; P < 0.01). Patients with LOS ≥ 2 days had a higher incidence of surgical site infection ( P < 0.01), hospital readmission ( P < 0.01), and revision surgery ( P < 0.01) over 30 days. Multivariable analysis demonstrated advanced age, female sex, African American race, Hispanic ethnicity, diabetes, smoking, and hypertension were independent risk factors for LOS ≥ 2 days.</p><p><strong>Conclusion: </strong>Despite removal from the inpatient-only list, a subset of outpatient THA remains at risk of an extended LOS. This study informs surgeons on the relevant risk factors of extended stay, enabling early inpatient preauthorization.</p>","PeriodicalId":51098,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons","volume":" ","pages":"1101-1107"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Orthopaedic Surgeons","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5435/JAAOS-D-23-00841","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The Centers for Medicare and Medicaid Services removed total hip arthroplasty (THA) from the inpatient-only list but continued to classify admissions as inpatient if they include two midnights, complicating care if an outpatient THA requires extended hospitalization. This study evaluates risk factors of patients undergoing outpatient-designated THA with a length of stay (LOS) ≥ 2 days.
Methods: A total of 17,063 THA procedures designated as outpatient in the National Surgical Quality Improvement Program database between 2015 and 2020 were stratified by LOS < 2 days (n = 2,294, 13.4%) and LOS ≥ 2 days (n = 14,765, 86.6%). Demographics, comorbidities, and outcomes were compared by univariate analysis. Multivariable regression analysis identified predictors of LOS ≥ 2 days.
Results: Outpatients with extended LOS were older (mean 65.3 vs. 63.5 years; P < 0.01); were more likely to have body mass index (BMI) > 35 (24.0 vs. 17.8%; P < 0.01); and had higher incidences of smoking (15.1% vs. 10.3%; P < 0.01), diabetes (15.4% vs. 9.9%; P < 0.01), chronic obstructive pulmonary disease (4.4% vs. 2.3%; P < 0.01), and hypertension (57.6% vs. 49.2%; P < 0.01). Patients with LOS ≥ 2 days had a higher incidence of surgical site infection ( P < 0.01), hospital readmission ( P < 0.01), and revision surgery ( P < 0.01) over 30 days. Multivariable analysis demonstrated advanced age, female sex, African American race, Hispanic ethnicity, diabetes, smoking, and hypertension were independent risk factors for LOS ≥ 2 days.
Conclusion: Despite removal from the inpatient-only list, a subset of outpatient THA remains at risk of an extended LOS. This study informs surgeons on the relevant risk factors of extended stay, enabling early inpatient preauthorization.
导言:美国医疗保险与医疗补助服务中心(Centers for Medicare and Medicaid Services)将全髋关节置换术(THA)从住院病人名单中删除,但如果住院时间包括两个午夜,则继续将其归类为住院病人,这使得门诊THA患者需要延长住院时间的护理工作变得更加复杂。本研究评估了住院时间(LOS)≥ 2 天的门诊指定 THA 患者的风险因素:在国家手术质量改进计划数据库中,2015年至2020年间共有17,063例THA手术被指定为门诊手术,按照LOS<2天(n=2,294,13.4%)和LOS≥2天(n=14,765,86.6%)进行了分层。通过单变量分析比较了人口统计学、合并症和结果。多变量回归分析确定了LOS≥2天的预测因素:结果:延长生命周期的门诊患者年龄更大(平均 65.3 岁 vs. 63.5 岁;P < 0.01);体重指数 (BMI) > 35 的可能性更大(24.0% vs. 17.8%;P < 0.01);吸烟发生率更高(15.1% vs. 10.3%;P < 0.01)。1% vs. 10.3%; P < 0.01)、糖尿病(15.4% vs. 9.9%; P < 0.01)、慢性阻塞性肺病(4.4% vs. 2.3%; P < 0.01)和高血压(57.6% vs. 49.2%; P < 0.01)。住院时间≥2天的患者在30天内手术部位感染(P<0.01)、再次入院(P<0.01)和翻修手术(P<0.01)的发生率较高。多变量分析表明,高龄、女性、非裔美国人、西班牙裔、糖尿病、吸烟和高血压是LOS≥2天的独立风险因素:结论:尽管从住院病人名单中删除了门诊 THA,但仍有一部分门诊 THA 存在延长 LOS 的风险。这项研究让外科医生了解了延长住院时间的相关风险因素,从而能够尽早进行住院预授权。
期刊介绍:
The Journal of the American Academy of Orthopaedic Surgeons was established in the fall of 1993 by the Academy in response to its membership’s demand for a clinical review journal. Two issues were published the first year, followed by six issues yearly from 1994 through 2004. In September 2005, JAAOS began publishing monthly issues.
Each issue includes richly illustrated peer-reviewed articles focused on clinical diagnosis and management. Special features in each issue provide commentary on developments in pharmacotherapeutics, materials and techniques, and computer applications.